Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
The FDA is changing protocols to prevent contamination of fresh and frozen berries with enteric viruses such as norovirus and ...
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
In India’s rapidly growing beauty sector, compliance with regulatory standards is not just a legal necessity but also a ...
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
GlobalData on MSN7d
FDA approves drug application for Lupin’s heart failure therapyThe US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
ThePrint on MSN11d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in IndiaTherapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
India Today on MSN7d
India approves living drug to treat blood cancer: All about Qartemi and how it worksThe second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood ...
Indian generic drugmaker Dr Reddy's Laboratories on Thursday said it was optimistic about the Donald Trump administration, as it believes the country would have an edge amid tensions between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback